Low serum levels of bone turnover markers are associated with perirenal fat thickness in patients with type 2 diabetes mellitus

被引:2
|
作者
Jia, Xiaoxia [1 ,2 ]
An, Yaxin [1 ,2 ]
Xu, Yuechao [1 ,2 ]
Yang, Yuxian [1 ,2 ]
Liu, Chang [1 ,2 ]
Zhao, Dong [1 ,2 ]
Ke, Jing [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Luhe Hosp, Ctr Metab & Immune Dis, Beijing, Peoples R China
[2] Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China
关键词
perirenal fat thickness; beta-C-terminal telopeptides of type I collagen; bone metabolism; type; 2; diabetes; RISK; WOMEN; FRACTURE; MASS; OSTEOPOROSIS; ADIPOSITY; PREDICTOR; DENSITY; DISEASE; OBESITY;
D O I
10.1530/EC-21-0449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Obesity is known as a common risk factor for osteoporosis and type 2 diabetes mellitus (T2DM). Perirenal fat, surrounding the kidneys, has been reported to be unique in anatomy and biological functions. This study aimed to explore the relationship between perirenal fat and bone metabolism in patients with T2DM. Methods: A total of 234 patients with T2DM were recruited from September 2019 to December 2019 in the cross-sectional study. The biochemical parameters and bone turnover markers (BTMs) were determined in all participants. Perirenal fat thickness (PrFT) was performed by ultrasounds via a duplex Doppler apparatus. Associations between PrFT and bone metabolism index were determined via correlation analysis and regression models. Results: The PrFT was significantly correlated with beta-C-terminal telopeptides of type I collagen (beta-CTX) (r = -0.14, P < 0.036), parathyroid hormone (iPTH) (r = -0.18, P <= 0.006), and 25 hydroxyvitamin D (25-OH-D)(r = -0.14, P = 0.001). Multivariate analysis confirmed that the association of PrFT and beta-CTX (beta = -0.136, P = 0.042) was independent of other variables. Conclusion: This study showed a negative and independent association between PrFT and beta-CTX in subjects with T2DM, suggesting a possible role of PrFT in bone metabolism. Follow-up studies and further research are necessary to validate the associations and to elucidate the underlying mechanisms.
引用
收藏
页码:1337 / 1343
页数:7
相关论文
共 50 条
  • [41] Serum vaspin levels are positively associated with diabetic retinopathy in patients with type 2 diabetes mellitus
    Yang, Hong-Wei
    Huang, Yong-gang
    Gai, Chun-liu
    Chai, Guang-rui
    Lee, Shufang
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (04) : 566 - 573
  • [42] Serum fetuin levels are associated with peripheral arterial disease in patients with type 2 diabetes mellitus
    Eleftheriadou, I.
    Grigoropoulou, P.
    Mourouzis, I.
    Liaskos, C.
    Kokkinos, A.
    Perrea, D.
    Makrilakis, K.
    Katsilambros, N.
    Tentolouris, N.
    DIABETOLOGIA, 2014, 57 : S523 - S523
  • [43] Association between bone turnover markers, bone mineral density, and serum osteoglycine in middle-aged men with Type 2 Diabetes mellitus
    Mostafa, Salma Mohamed
    Elebrashy, Ibrahim
    Haddad, Hemmat El
    Shaker, Olfat
    Razek, Naglaa Abdel
    Fayed, Ahmed
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [44] Biochemical markers of bone turnover in patients with type 2 diabetes and their correlations with HbA1c levels
    Ozkan, B.
    Ozkan, A.
    Capoglu, I.
    Umudum, Z.
    Sahin, Y.
    Alp, H.
    DIABETOLOGIA, 2007, 50 : S463 - S463
  • [45] Low serum osteocalcin levels are associated with diabetes mellitus in glucocorticoid treated patients
    H. Florez
    J. Hernández-Rodríguez
    J. L. Carrasco
    X. Filella
    S. Prieto-González
    A. Monegal
    N. Guañabens
    P. Peris
    Osteoporosis International, 2022, 33 : 745 - 750
  • [46] Low serum osteocalcin levels are associated with diabetes mellitus in glucocorticoid treated patients
    Florez, H.
    Hernandez-Rodriguez, J.
    Carrasco, J. L.
    Filella, X.
    Prieto-Gonzalez, S.
    Monegal, A.
    Guanabens, N.
    Peris, P.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (03) : 745 - 750
  • [47] ASSESSMENT OF SERUM ALARIN LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Kilinc, F.
    Demircan, F.
    Gozel, N.
    Onalan, E.
    Karatas, A.
    Pekkolay, Z.
    Ozdemir, F. A.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2020, 16 (02) : 165 - 169
  • [48] OSTEOPROTEGERIN AND RANKL SERUM LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Shepelkevich, Alla
    Lobashova, Veronika
    Salko, Olha
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S342 - S342
  • [49] Evaluation of Bone Markers in Type 2 Diabetes Mellitus
    Singh, Harjeet
    Kumar, Visesh
    Singh, Ajay Kumar
    Chaudhary, Surbhi
    ANNALS OF AFRICAN MEDICINE, 2024, 23 (03) : 324 - 327
  • [50] The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus
    Akyay, Ozlem Zeynep
    Canturk, Zeynep
    Selek, Alev
    Cetinarslan, Berrin
    Tarkun, Ilhan
    Cakmak, Yagmur
    Baydemir, Canan
    MEDICINE, 2023, 102 (39) : E35394